Subscribe to our Newsletters !!

    Biocon News

    Biocon gets EIR from USFDA for its small particles API Unit in Bengaluru

    Biocon has gotten the Establishment Inspection Report (EIR) from the U. S. Food and Drug Administration (FDA) for the Pre-Approval and GMP examination of its Small Molecules API Manufacturing Facility at Biocon Park SEZ, Bommansandra, Bengaluru, led between 20 January and 24 January 2020. At the finish of the review the office had given a Form